Antibody Therapeutics for Life

Notices

KAIST ADVANCED BIO HEALTH INNOVATION PROGRAM
  • Written by Admin
  • Written date 2019-06-21 10:27:36
  • Inquire 240

KAIST ADVANCED BIO HEALTH INNOVATION PROGRAM


PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a presentation at KAIST ADVANCED BIO HEALTH INNOVATION PROGRAM ( http://www.kaistbhp.com/ ). 

List





Prev Antibody Society KOREA(ASK) 2019
Next Bio Connection Australia 2019